ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients
Download pdf Results of an EBMT Phase III randomized trial on dose-reduced versus standard conditioning followed by allogeneic SCT for patients with MDS